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on untreated endothelium-denuded aortic rings (control) compared 
to 2-APB (100 µM) or UR95 (0.005, 0.02, and 0.08 mg/ml) pre-
treated endothelium-denuded aortic rings (*: P<0.05; **: P<0.01; 






Figure 4.10 (a) The vasoconstriction response-curves obtained from 
cumulative addition of CaCl2 on untreated endothelium-intact 
aortic rings (control) compared to nifedipine (0.1, 0.3, and 1 µM) 
or PN95 (0.005, 0.04, and 0.32 mg/ml) pre-treated endothelium-
intact aortic rings, (b) the vasoconstriction response induced by PE 
on untreated endothelium-denuded aortic rings (control) compared 
to 2-APB (100 µM) or PN95 (0.005, 0.04, and 0.32 mg/ml) pre-
treated endothelium-denuded aortic rings (*: P<0.05; **: P<0.01; 
***: P<0.001; n=8). 
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Figure 5.1 Vasodilatory effects of F1 and F4 in cumulative concentration of 
0.0025-1.2275 mg/ml on 1µM PE pre-contracted isolated 
endothelium-intact SD rat aortic rings (n=8). F1: extracts GE50, 
UR95, PT95, PN95, and AO50 combined in EC: 0, 25, 20, 20, and 
10, respectively. F4: extracts GE50, UR95, PT95, PN95, and 
AO50 combined in EC: 20, 15, 0, 20, and 10, respectively. The 
Rmax values were compared among each other to ensure the 
efficacy of F1. 
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Figure 5.2 Vasodilatory effects of F1, F1-1, F1-2, F1-3, F1-4, and F1-5 with 
cumulative concentration of 0.0025-0.3175 mg/ml on 1 µM PE 
pre-contracted isolated endothelium-intact SD rat aortic rings 
(n=8) (*: P<0.05, **: P<0.01, ***: P<0.001); F1-1: distilled water 
extract of five herbs using F1 ratio at 50°C; F1-2: 50% ethanolic 
extract of five herbs using F1 ratio at 50°C; F1-3: 95% ethanolic 
extract of five herbs using F1 ratio at 50°C; F1-4: total 95% of 
ethanolic extraction of U. rhynchophylla, P. thomsonii, and P. 
notoginseng (using F1 ratio) combined with AO50 (using F1 ratio) 
at 50°C; F1-5: distilled water extract of five herbs using F1 ratio at 
100°C; The Rmax values were compared among each other to 
determine the formula with the highest efficacy in terms of 
exerting vasodilatory effects. 
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Figure 5.3 The developed HPTLC plate examined under ultraviolet light at 
wavelength of (a) 366 nm, and (b) 254 nm, for (i) 
isorhynchophylline, (ii) rhynchophylline, (iii) F1, (iv) F1-1, (v) 
F1-2, (vi) F1-3, (vii) F1-4, and (viii) F1-5, with Rf scale provided 




Figure 5.4 The (a, b) developed and (c, d) derivatized HPTLC plate examined 
under ultraviolet light at wavelength of (a, c) 366 nm, and (b, d) 
254 nm, for (i) puerarin, (ii) F1, (iii) F1-1, (iv) F1-2, (v) F1-3, (vi) 
F1-4, and (vii) F1-5, with Rf scale provided at both sides. 
 
156 
Figure 5.5 The derivatized HPTLC plate examined under ultraviolet light at 
wavelength of (a) 366 nm, and (b) 254 nm, as well as (c) white 




1, (v) F1-2, (vi) F1-3, (vii) F1-4, and (viii) F1-5, with Rf scale 
provided at both sides. 
 
Figure 5.6 The derivatized HPTLC plate examined under ultraviolet light at 
wavelength of (a) 366 nm, and (b) 254 nm, as well as (c) white 
light, for (i) alisol b acetate (ii) F1, (iii) F1-1, (iv) F1-2, (v) F1-3, 
(vi) F1-4, and (vii) F1-5, with Rf scale provided at both sides. 
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Figure 5.7 Representative 1D-IR spectra of (i) F1, (ii) F1-1, (iii) F1-2, (iv) 
F1-3, (v) F1-4, and (vi) F1-5 in wavelength ranging among 4000-
400 cm
-1
, respectively.  
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Figure 5.8 Representative SD-IR spectra of (i) F1, (ii) F1-1, (iii) F1-2, (iv) 






Figure 5.9 Representative autopeaks, 2D-IR, and 3D-IR spectra of (a) F1, (b) 
F1-1, (c) F1-2, (d) F1-3, (e) F1-4, and (f) F1-5 in wavelength 
ranging between 1600-850 cm
-1
.   
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Figure 6.1 The cumulative concentration-response curves of F1-2 
vasodilatory effects on PE-primed endothelium-intact aortic rings 
(control) compared to the vasodilatory effects exerted by F1-2 on 
the PE-primed endothelium-denuded aortic rings or KCl-primed 
endothelium-intact aortic rings. (+E: endothelium-intact aortic 
rings; -E: endothelium-denuded aortic rings; *: P<0.05; **: 
P<0.01; ***: P<0.001; n=8). 
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Figure 6.2 The cumulative concentration-response curves of F1-2 
vasodilatory effects on PE-primed endothelium-intact aortic rings 
(control) compared to vasodilatory effects exerted by F1-2 upon 
L-NAME, ODQ, MB, or indomethacin pre-treated PE-primed 
endothelium-intact aortic rings (+E: endothelium-intact aortic 
rings; *: P<0.05; **: P<0.01; ***: P<0.001; n=8). 
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Figure 6.3 The cumulative concentration-response curves of F1-2 
vasodilatory effects on PE-primed endothelium-intact aortic rings 
(control) compared to the vasodilatory effects exerted by F1-2 
upon atropine or propranolol pre-treated PE-primed endothelium-
intact aortic rings (+E: endothelium-intact aortic rings; *: P<0.05; 
**: P<0.01; ***: P<0.001; n=8). 
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Figure 6.4 The cumulative concentration-response curves of F1-2 
vasodilatory effects on PE-primed endothelium-intact aortic rings 
(control) compared to the vasodilatory effects exerted by F1-2 
upon TEA, glibenclamide, 4-AP, or BaCl2 pre-treated PE-primed 




rings; *: P<0.05; **: P<0.01; ***: P<0.001; n=8). 
 
Figure 6.5 (a) The vasoconstriction response-curves obtained from 
cumulative addition of CaCl2 on untreated endothelium-intact 
aortic rings (control) compared to nifedipine (0.1, 0.3, and 1 µM) 
or F1-2 (0.005, 0.02, and 0.08 mg/ml) pre-treated endothelium-
intact aortic rings, (b) the vasoconstriction response induced by PE 
on untreated endothelium-denuded aortic rings (control) compared 
to 2-APB (100 µM) or F1-2 (0.005, 0.02, and 0.08 mg/ml) pre-
treated endothelium-denuded aortic rings (*: P<0.05; **: P<0.01; 
***: P<0.001; n=8). 
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Figure 6.6 Effects of 0.97092 g/kg (high dose), 0.48546 g/kg (medium dose), 
and 0.24273 g/kg (small dose) of F1-2, and 80 mg/kg propranolol 
(positive control) on (a) systolic blood pressure (SBP), (b) 
diastolic blood pressure (DBP), and (c) mean arterial pressure 
(MAP) of SHRs during 28 days of orally administration and 
compared to the control group (*: P<0.05; **: P<0.01; ***: 
P<0.001; Mean±S.E.M.; n=6). 
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Figure 6.7 The changes of body weight on 0.97092 g/kg (high dose), 0.48546 
g/kg (medium dose), and 0.24273 g/kg (small dose) of F1-2-
treated groups, and 80 mg/kg propranolol-treated group (positive 
control), as well as the untreated group of SHRs during the 28 
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PENGOPTIMUMAN KESAN ANTIHIPERTENSIF DAN VASORELAKSAN 
SECARA FARMAKOLOGI BAGI EKSTRAK UBATAN TRADISIONAL CINA 
POLIHERBA BERDASARKAN PENDEKATAN KESERASIAN TINDAK 
BALAS  RANGSANGAN ORTOGONAL 
 
ABSTRAK 
Hipertensi merupakan salah satu masalah kesihatan yang utama dan berkaitan 
dengan pelbagai penyakit seiring dan komplikasi, kebanyakan komplikasi berlaku pada 
buah pinggang serta sistem kardiovaskular dan hal ini telah mendapat perhatian saintis di 
seluruh dunia kebelakangan ini. Walaupun terdapat ubat-ubatan antihipertensi sintetik di 
pasaran, efikasi yang rendah dalam kaedah monoterapi, serta kesan sampingan kerap 
dilaporkan. Oleh itu, kajian ini bertujuan mewujudkan satu formula antihipertensi baru 
dengan menggunakan teori gabungan sindromik-penyakit yang baharu daripada kaedah 
perubatan tradisional Cina (TCM). Pemilihan herba TCM untuk kajian ini iaitu 
Gastrodia elata, Uncaria rhynchophylla, Pueraria thomsonii, Panax notoginseng, dan 
Alisma orientale adalah berdasarkan keupayaan herba-herba ini dalam merawat tiga 
sindrom utama tekanan darah tinggi seperti api, pengekalan cecair kahak, dan sindrom-
sindrom difisiensi. Keutuhan kelima-lima herba mentah telah disahkan oleh 
kromatografi lapisan nipis berprestasi tinggi (HPTLC) dan kaedah spektroskopi 
inframerah dengan teknik pembetulan Fourier tiga fasa (FTIR) sebagai pengesahan cap 
jari sebelum eksperimen. Kesan vasodilatori kesemua ekstrak telah disiasat dengan 
menggunakan asai in vitro cincin aortic terpencil. Ekstrak etanolik 95% U. 
rhynchophylla (UR95), P. thomsonii (PT95), dan P. notoginseng (PN95), serta ekstrak 
etanolik 50% G. elata (GE50), dan A. orientale (AO50) didapati sebagai ekstrak yang 
xxx 
 
paling kuat dalam pendorongan kesan vasodilatori berbanding dengan ekstrak dalam 
pelarut lain. Oleh itu, ekstrak ini telah digunakan untuk kajian keserasian kumpulan 
ortogonal rangsangan-tindakan, dan nisbah yang terbaik (F1) didapati pada EC0, EC25, 
EC20, EC20 dan EC10 masing-masing adalah GE50 UR95, PT95, PN95, dan 
AO50. Selain itu, ekstrak (F1-2) lima herba mentah yang telah disediakan dalam nisbah 
F1 dan diekstrak dalam etanol  sebanyak 50% seterusnya disahkan sebagai ekstrak yang 
paling kuat dalam pameran kesan vasodilatori berbanding dengan ekstrak yang lain 
melalui nilai EC50 dan Rmax pada 0.028±0.005 mg/ml dan 101.71±3.64%. Kesan 
vasodilatori F1-2 adalah disebabkan tetapi bukan sahaja terhad kepada isorinkofilin, 
rinkohfilin, puerarin, ginsenosida Rg1 dan Rb1, serta asitat alisol b melalui 
NO/sGC/cGMP, adrinerjik-β2 dan reseptor-M3, serta mekanisme rangkaian isyarat Kca, 
Kv, Kir, KATP, VOCC dan IP3R. Kesan antihipertensi F1-2 telah ditentukan dengan lebih 
lanjut secara in vivo selama 28 hari dengan penyuapan sub-kronik dalam tikus hipertensi 
spontan (SHRs). Hasil kajian menunjukkan penurunan yang ketara dalam tekanan darah 
SHR berbanding dengan kumpulan kawalan bergantung kepada dos, manakala tidak 
menyebabkan apa-apa kesan sampingan di darah elektrolit urea serum, fungsi buah 
pinggang, fungsi hati, kiraan darah lengkap, dan kiraan pengkamiran tikus SHR 
walaupun sehingga dos yang tinggi (970.92 mg/kg) penyuapan F1-2 dalam model 
haiwan. Secara muktamadnya, F1-2 dijumpai sebagai berjaya dan berpotensi sebagai 







PHARMACOLOGICAL OPTIMIZATION OF THE ANTIHYPERTENSIVE 
AND VASORELAXANT EFFECTS OF A POLYHERBAL TRADITIONAL 
CHINESE MEDICINE EXTRACT BASED ON ORTHOGONAL STIMULUS-
RESPONSE COMPATIBILITY APPROACH 
 
ABSTRACT 
Hypertension is one of the major health concerns that are related to various 
concomitant diseases as well as complications that mainly occur in kidney and 
cardiovascular system and it has gained the attention of worldwide scientists in recent. 
Despite the availability of synthetic anti-hypertensive drugs in the market, the low 
efficacies in monotherapy, as well as adverse effects are frequently being reported. 
Hence, the current study decided to establish a new antihypertensive formula by 
applying a new syndromic-disease combination theory of traditional Chinese medicine 
(TCM). The selection of TCM herbs for current study which includes Gastrodia elata, 
Uncaria rhynchophylla, Pueraria thomsonii, Panax notoginseng, and Alisma orientale 
was based on their abilities to treat three main syndromes of hypertension such as fire, 
phlegm fluid retention, and deficiency syndromes. The authenticity of the five raw herbs 
was verified by high performance thin layer chromatography (HPTLC) and tri-step 
Fourier transform infrared (FTIR) fingerprints identification methods prior to the 
experiments. The vasodilatory effects of all extracts were investigated by using the in 
vitro isolated aortic rings assays. The 95% ethanolic extracts of U. rhynchophylla 
(UR95), P. thomsonii (PT95), and P. notoginseng (PN95), as well as 50% ethanolic 
extracts of G. elata (GE50), and A. orientale (AO50) were found as the most potent 
extracts for exerting vasodilatory effects compared to other solvent extracts. Hence, 
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these extracts were used for orthogonal stimulus-response compatibility group studies, 
and the best ratio (F1) was found at EC0, EC25, EC20, EC20, and EC10 for GE50, UR95, 
PT95, PN95, and AO50, respectively. Moreover, the extract (F1-2) of five raw herbs 
which were prepared in F1 ratio and extracted in total by 50% ethanol was further 
confirmed as the most potent extract in exhibiting vasodilatory effects compared to any 
other extracts at EC50 and Rmax values of 0.028±0.005 mg/ml and 101.71±3.64%, 
respectively. The vasodilatory effects of F1-2 were elicited by but not limited to 
isorhynchophylline, rhynchohpylline, puerarin, ginsenosides Rg1 and Rb1, and alisol b 
acetate through NO/sGC/cGMP, β2-adrenergic and M3-receptors, and also Kca, Kv, Kir, 
KATP, VOCC, and IP3R signaling mechanism pathways. The antihypertensive effects of 
F1-2 were further determined in vivo by 28 days sub-chronic oral administration in 
spontaneous hypertensive rats (SHRs). Results showed significant decrease of SHRs 
blood pressure compared to negative control in dose-dependent manner, whilst without 
causing any adverse effects in the blood urea serum electrolyte, renal function, liver 
function, full blood count, and differential count of the SHRs even until the high dose 
(970.92 mg/kg) of F1-2 administration. Conclusively, F1-2 was discovered to be a 










Hypertension is a well-known “silent killer” and is one of the major risk factors of 
cardiovascular diseases. It is defined as persistently high blood pressure (BP) exerted 
against the wall of the arteries. There are approximately 13% of human populations in 
the earth suffering from hypertension and majority of them are from developing 
countries. In 2013, there was more than 32.7% of Malaysian aged ≥ 18 years old, and 
43.5% of Malaysian aged ≥ 30 years old suffering from hypertension (MOH, 2013). The 
World Health Organization (WHO) has rated the hypertension as one of the most deadly 
causes of premature deaths worldwide. Hypertension is asymptomatic, it can live in 
anyone of us without causing any symptoms, and lead to concomitant diseases after 
many years, such as stroke. 
Hypertension is categorized into several stages according to the American Heart 
Association (AHA) and Joint National Committee 7 (JNC 7). Normal BP stage has 
systolic pressure ≤ 120 mmHg and diastolic pressure ≤ 80 mmHg; pre-hypertension 
stage has systolic pressure ranging between 120-139 mmHg or diastolic pressure ranging 
between 80-89 mmHg; stage 1 hypertension has systolic pressure between 140-159 
mmHg or diastolic pressure between 90-99 mmHg; and stage 2 hypertension has systolic 
pressure ≥ 160 mmHg or diastolic pressure ≥ 100 mmHg. In addition, a person with 
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systolic pressure of ≥ 180 mmHg or diastolic pressure ≥ 110 mmHg are considered as 
critical and should be treated immediately as medical emergency.  
Generally, there are three types of blood vessels which includes the artery, vein, and 
capillary, they are responsible in transporting blood throughout the whole body. There 
are three layers present in artery and vein, where the outer most layer known as tunica 
adventitia, middle layer as tunica media, and innermost layer as tunica intima. Tunica 
media is rich of vascular smooth muscle cells (VSMCs), whereas tunica intima is 
composed of a thin layer of endothelial cells. Both the VSMCs and endothelium are the 
place where the vasomotors are located (Jakala et al., 2009, Yildiz et al., 2013). From 
the literatures, different parts of blood vessels were used by different researchers for 
vasculatures studies. However, based on the statistical analysis tabulated from 2010-
2015, there were approximately 67% of the researches who recommend the use of aorta 
as the “golden tool” for pharmacological research in regards to vasculature, in order to 
minimize the orientation change of VSMCs and reduce the probability of causing 
damage to the endothelium (Loh et al., 2016). Generally, the vasomotors can cause the 
vascular tone to react in two ways such as vasodilation or vasoconstriction where both 
reactions are strictly dependent on the dominancy of the receptors present on the 
vascular endothelium and VSMCs as well as the interactions between their signals.  
1.2 Endothelium-Derived Relaxing Factors (EDRFs) 
There are two well-characterized EDRFs present in endothelium such as nitric oxide 
(NO) and prostacyclin (PGI2). Additionally, the endothelium-derived hyperpolarizing 
factor (EDHF), and hydrogen sulfide (H2S) have been claimed to be one of the EDRFs 




1.2.1 Nitric oxide (NO) 
Generally, the NO can be produced by three isoform of NO synthase (NOS) such as 
neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). In 
endothelium, the increase in the concentration of the calcium in cytosol will enhance the 
formation of calcium-calmodulin complexes, which will activate the calmodulin-binding 
domain of the eNOS, and causes NO production. Other than that, the increase in 
hemodynamic shear stress, protein kinase A (PKA), and protein kinase B (Akt) in the 
blood vessel will induce the phosphorylation of the eNOS at Ser1179 site (Quillon et al., 
2015, Zhao et al., 2015). Once the eNOS is activated, it will catalyze the breakdown of 
L-arginine into NO. Subsequently, NO will diffuse into adjacent VSMCs to stimulate 
the activity of the components down its signaling cascade such as soluble guanylyl 
cyclase (sGC), cyclic guanosine monophosphate (cGMP), and protein kinase G (PKG), 
hence resulting in vasodilation (Jakala et al., 2009, Moncada, 2007). The production of 
the NO can further stimulate the Kca channels (Bolotina et al., 1994, Li et al., 1997) and 
voltage-activated K
+
 channels (Kv) through the sGC-independent pathway (Yuan et al., 
1996). Regarding the mechanism study, the selective antagonist of eNOS, L-N
G
-Nitro 
arginine methyl ester (L-NAME) is frequently used due to its low toxicity, and more 
solubility at neutral pH compared to other inhibitors (Balligand et al., 1993, Pfeiffer et 
al., 1996). 
1.2.2 Prostacyclin (PGI2) 
It is also known as prostaglandin I2, and is well-known as one of the important 
EDRFs which is capable of inhibiting platelet aggregation. In endothelium, the precursor 
of the PGI2 is arachidonic acid (AA) which ordinarily exists in the phospholipid bilayer 
of membranes. The AA will be released into the cytosol either catalyzed by 
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phospholipase A2 (PLA2) or diacylglycerol (DAG) lipase by breaking down the 
phospholipid. The free mobile AA will be converted into prostaglandin H2 (PGH2) by 
cyclooxygenase (COX). Subsequently, the prostacyclin synthase will catalyze the 
breakdown of PGH2 into PGI2, whilst some of the PGH2 is converted into thromboxane 
(TXA2) by thromboxane synthase. Both the TXA2 and PGI2 functions are 
physiologically antagonize. The PGI2 will bind to the prostacyclin receptor (IP) which is 
located on the membrane of the VSMCs. IP is a Gsα protein-coupled receptor, once the 
Gsα protein is bound to guanosine triphosphate (GTP), the membrane-bound adenylyl 
cyclase (AC) will be stimulated to convert the adenosine triphosphate (ATP) into 3’,5’-
cyclic adenosine monophosphate (cAMP), which will then activate the PKA, and causes 
vasodilatory effects (Berumen et al., 2012, Nichols and Nichols, 2008). In the 
mechanism studies, the non-selective COX inhibitor, indomethacin which is a non-
steroidal anti-inflammatory drug (NSAID) is frequently used compared to others such as 
ibuprofen, meclofenamic acid, and diclofenac. Indomethacin is preferred because it can 
bind rapidly to the COX with high-affinity, is time-dependent and has slow reversibility 
(Dannhardt and Kiefer, 2001, Smith et al., 2000). 
1.2.3 Endothelium-derived hyperpolarizing factors (EDHFs) 
EDHFs were discovered when there were residual of endothelium-dependent 
relaxation observed even after the depletion of both NO and PGI2 (Scotland et al., 2005, 
Wang, 2002). It is a kind of electrical signal that originated from the endothelium, which 
could subsequently induce the hyperpolarizing current in adjacent VSMC and cause 
vasodilatory effect. In vasculature, EDHF can be generated through various kinds of the 
reactions that happens between different biochemical components. For instance, part of 
the AA in the endothelium could be broken down into epoxyeicosatrienoic acids (EETs) 
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 channels (IKca) which is located on the endothelium, hence causing the K
+
 
ions efflux, and induce the hyperpolarizing current that will be passed onto the adjacent 
VSMCs via the myoendothelial gap junction, which was electrically-coupled between 
both endothelial cells and VSMCs, and ultimately causing the VSMCs hyperpolarization 
and relaxation. Furthermore, the EETs can activate the transient receptor potential 
vanilloid 4 (TRPV4) that is located on the endothelium to allow Ca
2+
 influx into the 
cytosol, and subsequently causes an increase of intracellular calcium concentration (Ca
2+ 
spark) due to the calcium-induced calcium release (CICR) reaction when the influx 
cytosolic Ca
2+
 stimulates the ryanodine receptors (RyRs) that are located on the 
sarcoplasmic reticulum (SR). However, in terms of action potential, the efflux of K
+ 
ions 
into the myoendothelial space leads to an increase in concentration of K
+
, causing the 
activation of the inwardly-rectifying K
+
 channels (Kir) on the VSMCs to allow the influx 
of K
+
 ions back into the cytosol of VSMCs, and followed by efflux of K
+





 channels (BKca) to extracellular and causes 
hyperpolarization, resulting in vasodilatory effect (Pires et al., 2013, Quyyumi and 
Ozkor, 2006).  
1.2.4 Hydrogen sulfide (H2S) 
H2S has a similar chemical profile as NO in vasculature. In the endothelium, the H2S 
is produced from the L-cysteine which is catalyzed by cystathionine γ-lyase (CSE) 
and/or cystathionine β-synthase (CBS). The H2S is capable of activating the IKca and 
SKca channels in endothelium, hence producing the hyperpolarizing current. Literatures 
stated that the production of H2S could be increased at least two-fold in endothelium 
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when triggered by the VEGF and muscarinic receptors activation through the Ca
2+
-
calmodulin-dependent activation of the CSE (Coletta et al., 2012, Wang, 2009). 
Moreover, H2S is diffusible into the adjacent VSMCs to inhibit the ATP from binding 
with ATP-sensitive K
+ 
channels (KATP), hence activating the channels and subsequently 
allowing the K
+
 efflux which results in hyperpolarization. H2S is also capable of 
inhibiting the phosphodiesterase 5 (PDE5) from breaking down the cGMP, hence 
enhances the vasodilatory effects.  
1.3 Enzyme-Linked Receptors 
These receptors can be called catalytic receptors which are located on the membrane. 
These receptors are functionally activated by catalytic enzymes and ligand-receptors. In 
vasculature, the guanylyl cyclase and serine-threonine protein kinases are the major 
enzyme-linked receptors that play the roles in vascular tone regulation. 
1.3.1 Soluble guanylyl cyclase (sGC) 
As aforementioned, the sGC is freely mobile in the cytosol of VSMCs which will be 
activated once the NO comes to bind with the heme group of sGC. Once the sGC is 
activated, it will cleave the GTP into cGMP, subsequently activates the PKG, and causes 
vasodilatory effect (Horowitz et al., 1996, Ko et al., 2008). The 1H-[1,2,4] oxadiazolo 
[4,3-a]quinoxalin-1-one (ODQ) is soluble in dimethyl sulfoxide (DMSO) and was 
reported to inhibit the sGC by oxidizing the heme group of the sGC (Moro et al., 1996, 
Olson et al., 1997, Schrammel et al., 1996) and it is more frequently being used 
compared to the other cGMP lowering agent, methylene blue (MB) (Kontos and Wei, 





1.3.2 Serine-threonine protein kinases 
It is basically a group of kinase enzymes that is functionally activated when bound to 
their respective secondary messengers, and subsequently phosphorylates the hydroxyl 
(OH) group of serine or threonine side chain of proteins which results in physiological 
effects. In vascular tone regulation, the protein kinases involved are PKA, PKC, and 
PKG. 
1.3.2(a) Protein kinase A (PKA) 
PKA is also known as the cAMP-dependent protein kinase which is functionally 
activated once bound with cAMP. Once bound with cAMP, its detaching catalytic 
subunits will phosphorylates the serine or threonine sites of its substrate proteins, and 
causes vasodilatory effect, whilst the cAMP will be broken down into adenosine 
monophosphate (AMP) by phosphodiesterase 3 (PDE3) (Bowen and Haslam, 1991). 
Regarding this mechanism study on cAMP-dependent PKA pathway, the Rp-cAMPs is 
commonly used due to its cell-permeability, resistance to PDE degradation as well as its 
selectivity towards PKA (Bouschet et al., 2003).  Additionally, the selective inhibitor for 
PDE 3 that is commonly used is milrinone.  
1.3.2(b) Protein kinase C (PKC) 
In both vascular endothelium and VSMCs, the PKC will be activated by DAG and 
binds with Ca
2+
 ions at C1 and C2 domain, respectively (Huang, 1989). Once the PKC is 
activated, it will phosphorylate the serine or threonine sites of its substrate proteins, 
hence causes vasoconstriction. The most commonly used blockers for PKC is BIM due 





1.3.2(c) Protein kinase G (PKG) 
As aforementioned, the PKG will be functionally activated once the cGMP binds to 
the regulatory units of the PKG without causing enzyme dissociation. After that, the 
activated catalytic units of the enzyme will phosphorylates the serine or threonine sites 
of its substrate proteins, and causes vasodilatory effect (Wall et al., 2003), whilst the 
cGMP will be broken down into guanosine monophosphate (GMP) which is catalyzed 
by PDE 5 (Paul and Snyder, 2012). The most commonly used cGMP-dependent PKG 
inhibitor is Rp-8-Br-PET cGMPs due to its high stability and the ability to block both 
PKG 1 and PKG 2 (Valtcheva et al., 2009). Additionally, the selective inhibitors for 
PDE 5 commonly used are sildenafil, dipyridamole, zaprinast and T-1032.  
1.4 G Protein-Coupled Receptors (GPCRs) 
GPCRs are also known as the seven-transmembrane domain receptors which are 
functionally activated when bound to its ligands to transmit the signals from the outside 
of the cell into its interior. Generally, there are three types of guanine nucleotide binding 
protein (G protein) subunits such as Gα, Gβ, and Gγ proteins, and the former is the one 
who plays the major role in vascular tone regulation which is further classified into at 
least three main sub-types such as Gqα, Giα, and Gsα. The activation of the G protein 
will be initiated once the GPCRs bind to its ligand which subsequently causes the G 
protein temporary acting as guanine nucleotide exchange factor (GEF) by changing its 
conformation, and exchange its guanosine diphosphate (GDP) into GTP. Once bound 
with GTP, the G protein trimer will be dissociated into Gα-GTP monomer and Gβγ 
dimer. Gα-GTP monomer will start to interact with their intracellular proteins for signal 
transduction and will be discussed in below session (Walaas et al., 1992), whereas Gβγ 
dimer will tend to activate certain types of signaling molecules including ion channels, 
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lipid kinases, phospholipases as well as its own signaling cascades (Dorsam and Gutkind, 
2007, Yuen et al., 2010).  
1.4.1 Gqα protein-coupled receptors 
In vasculature, the activation of the Gqα protein will cleave the phosphatidylinositol 
4,5-bisphosphate (PIP2) into second messengers, inositol triphosphate (IP3) and DAG by 
binding its Gqα-subunit to the phospholipase C (PLC). The IP3 is soluble and diffusible 
in cell and binds to the intracellular receptor, IP3 receptor (IP3R) which is located inside 
the cell and on the sacroplasmic reticulum (SR) to trigger the intracellular release of the 
Ca
2+
 ions from the SR into the cytosol. Whereas, the DAG will activate the PKC and 
result in the increase of Ca
2+ 
concentration in cytosol. In vasculature, the Gqα protein-
coupled receptors that are present in endothelium includes angiotensin-2 receptor (AT2), 
serotonin receptor (5-HT1D), bradykinin receptor (B2), muscarinic-3 receptor (M3), 
endothelin-B receptor (ETBR), and calcitonin receptor-like receptor (CALCRL). 
Whereas, there are α1-adrenergic receptor (α1), M3 receptor, angiotension-1 receptor 
(AT1), endothelin receptors (ETAR & ETBR), serotonin receptor (5-HT2), and 
thromboxane receptor (TXA2) present in VSMCs (Bockaert et al., 2006, Chen et al., 
2000, de Gasparo et al., 2000, Goodman et al., 2001, Ishii and Kurachi, 2006, Jakala et 
al., 2009, Klabunde, 2011, Yildiz et al., 2013). 
1.4.2 Giα protein-coupled receptors 
In vasculature, there is a Giα protein-coupled receptor present in the VSMCs such as 
α2-adrenergic receptor (α2). Once this receptor is activated by its agonist, it will inhibit 
the activity of the cAMP-dependent AC to convert ATP into cAMP, hence causes 




1.4.3 Gsα protein-coupled receptors 
Typically, the Gsα protein-coupled receptor is functionally opposed to Giα protein-
coupled receptor, where it will activate AC to produce cAMP from ATP, the increase in 
the production of cAMP will subsequently enhance the activation of PKA and results in 
vasodilatory effect. There are at least two major Gsα protein-coupled receptors present in 
VSMCs such as β2-adrenergic receptor (β2) and PGI2 receptor (IP) (Jakala et al., 2009, 
Klabunde, 2011). In addition, the commonly used AC inhibitor for mechanism study is 
SQ22536 because it is more selective towards AC, higher cell-permeability and better 
solubility.  
1.5 Channel-Linked Receptors 
These channels are also known as ion channel-linked receptors and/or ligand-gated 
receptors and/or ionotropic receptors. These receptors will be functionally activated 







), and calcium (Ca
2+
) move through the membrane. In vasculature, the 
action potential which occurs in VSMCs will be regulated by these receptors through 
hyperpolarization or depolarization. There are two important channel-linked receptors 




 channels.  





 channel is the most widely distributed types of ion channel in living organisms 
(Littleton and Ganetzky, 2000). Typically, there are four types of K
+
 channels frequently 
discussed and investigated in vascular tone regulation which includes calcium-activated 
K
+
 channel (Kca), voltage-gated K
+
 channel (Kv), ATP-sensitive K
+
 channel (KATP), and 
inwardly-rectifying K
+






 channel (Kca) 
In human vasculature, Kca channel can be further divided into three subtypes 
including big-conductance Kca channel (BKca), intermediate-conductance Kca channel 
(IKca), and small-conductance Kca channel (SKca). BKca channel is widely distributed in 
VSMCs, whereas IKca and SKca channels are abundantly expressed in endothelium 
(Ding et al., 2002, Eichler et al., 2003, Jakala et al., 2009, Marchenko and Sage, 1996). 
The electric conductance for BKca, IKca, and SKca channels ranges between 100-300, 25-
100, and 2-25 pS, respectively. In VSMCs, the BKca channel is voltage and Ca
2+
-
dependent, it will be activated by the increased intracellular Ca
2+
 concentration, which 
allows the efflux of K
+
 ions from the cytosol, hence creating hyperpolarization and the 
closure of the Ca
2+
 channels, which results in vasodilatory effect (Feletou and Vanhoutte, 
2005, Gautam et al., 2006). Furthermore, BKca channel can be indirectly stimulated by 
the activation of PKA and PKG (Robertson et al., 1993, Scornik et al., 1993). IKca and 
SKca channels are slightly different from BKca channel by which they are voltage-
insensitive (Barfod et al., 2001, Hirschberg et al., 1998, Xia et al., 1998), but highly 
sensitive to the Ca
2+
 and calmodulin concentration in cytosol (Garcia Pascual et al., 1995, 
Schumacher et al., 2001). The commonly used selective antagonist for BKca, IKca, and 
SKca are iberiotoxin, clotrimazole, and apamin, respectively.  
1.5.1(b) Voltage-activated K
+
 channel (Kv) 
In vasculature, the activation of Kv channel is strictly dependent on the voltage 
changes across the membrane and is functionally correlated with the voltage-operated 
Ca
2+
 channel (VOCC) in maintaining the membrane potential of VSMCs. Kv channel 
will reverse the depolarizing state of  the membrane potential back to steady state 
(Nelson and Quayle, 1995). Typically, there are two major subunits for Kv channel 
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which are the alpha subunits, which can be further grouped into 12 subclasses, and the 
beta subunits. They are functionally activated to hasten the efflux of K
+
 from the cytosol 
out to the exterior, hence a more rapid increase of repolarizing current, with less 
activation of Ca
2+
 channels (Jakala et al., 2009, Robertson and Nelson, 1994, Yildiz et 
al., 2013). In addition, the cAMP-dependent PKA can indirectly increase the amplitude 
of the Kv currents (Aiello et al., 1995) and inhibited by the activation of PKC (Cole et al., 
1996). The commonly used inhibitor for its mechanism study is 4-aminopyridine (4-AP).  
1.5.1(c) Inwardly-rectifying K
+
 channel (Kir) 
This channel contains pore domain which is homologous to Kv channel, and 
therefore it has been classified as one of the member in Kv channel. The Kir channel 
needs to bind with PIP2 to be activated, and functionally prefer the inward flow of the K
+
 
ions rather than outward, hence hastening the recovery of the membrane potential back 
to resting state (Feletou and Vanhoutte, 2005, Ganong, 1993, Tucker and Baukrowitz, 
2008). The activation of this channel in endothelium will contribute as EDHFs for 
inducing the relaxing of VSMCs (Edwards et al., 1998). The only different of Kir 
channel compared to other K
+
 channels is it will only be activated when the membrane 
potential has reached hyperpolarization state, then allowing the influx of K
+ 
ions into the 
cytosol to reach resting potential (Edwards and Weston, 1995). The only selective 
antagonist used for the Kir channel study is barium chloride (BaCl2). 
1.5.1(d) ATP-sensitive K
+
 channel (KATP) 
This channel will be activated by increasing intracellular ADP and decreasing 
intracellular ATP, also called ATP-sensitive channel and is located in VSMCs (Ashcroft 
and Ashcroft, 1990, Boyd et al., 1990, Ko et al., 2008, Standen et al., 1989). In resting 
potential, KATP channel acts as a weak inwardly rectifying K
+
 channel, thus it was 
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classified as a member in Kir channel family. However, once KATP channel is activated, 
it will produce K
+
 efflux from the cytosol to maintain a negative resting potential, hence 
causing vasodilatory effect (Jakala et al., 2009). The commonly used selective KATP 
channel inhibitor for mechanism study is glibenclamide.  





 ion-linked receptor is selectively permeable for Ca
2+
 ions and allows its 
entrance into the cytosol, hence creates depolarization, and induces vasoconstriction. 
Typically, there are two different types of Ca
2+
 channel such as VOCC and receptor-
operated Ca
2+
 channels (ROCC). Generally, there are two ways to increase the cytosolic 
Ca
2+
 concentration which are through 1) the influx of Ca
2+
 ions from exterior or 2) 
intracellular release of Ca
2+
 from the SR store. Ca
2+
 ion is one of the most crucial second 
messengers in vascular tone regulation. The intracellular increase of Ca
2+
 concentration 
will cause membrane depolarization and allow the up-regulation of Ca
2+
-calmodulin 
complexes. In the cross-bridge cycle in VSMCs, the activated calmodulin will stimulate 
the MLC kinases (MLCK) to phosphorylate the MLC at serine residue-19 to form a 
cross-bridge with the actin filament, and again form actin-myosin protein (AMP), hence 
causes the VSMCs contraction via the sliding filament mechanism (Gao et al., 2003, 
Jakala et al., 2009, Marchenko and Sage, 1996, Webb, 2003). In addition, there is 
another enzyme in this cross-bridge, the MLC phosphatases (MLCP) which can 
dephosphorylate the MLC in order to terminate the smooth muscle contraction. 
1.5.2(a) Voltage-operated Ca
2+
 channel (VOCC) 
In vasculature, VOCC is one of the most important receptors used to control the 
vascular tone by maintaining the membrane potential of the VSMCs. Here, the VOCC is 
normally referred to as the L-type Ca
2+
 channel that is in VSMCs. In normal 
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physiological condition, the concentration of the Ca
2+
 ions outside the cell is around 3-4 
mM which is thousand-fold compare to inside the cell, which is normally kept at or 
below 100nM (McFadzean and Gibson, 2002). Therefore, once the membrane potential 
reached depolarization stage, the Ca
2+
 ions will rush into the cytosol from the outside via 
VOCC, hence results in vasoconstriction (Goodman et al., 2001).It is functionally 
correlated with Kv channel in controlling the membrane potential. The commonly used 
antagonist for this channel mechanism study is nifedipine due to its highly vascular 
selectivity (Furberg et al., 1995). 
1.5.2(b) Receptor-operated Ca
2+
 channel (ROCC) 
The calcium cannot only enter the VSMCs by Ca
2+
 influx via VOCC, but also 
through intracellular Ca
2+
 release via the ROCC that could lead to the membrane 
depolarization (Berridge, 1997, Gibson et al., 1998). The ROCC normally refer to 
certain members of GPCRs that are capable of inducing the intracellular release of Ca
2+
 
ions from the SR store into the cytosol by producing its second messenger (Landsberg 
and Yuan, 2004, McFadzean and Gibson, 2002). Typically, there are at least three types 




1.5.2(b)(i) Inositol triphosphate receptor (IP3R) 
The IP3R is located on the surface of the SR, which will be activated by the second 
messenger, IP3 that is produced by activated Gqα protein-coupled receptors. It is the 
main site for the intracellular Ca
2+
 release from the SR store into the cytosol which leads 
to an increase in the formation of Ca
2+
-calmodulin complexes (Putney et al., 2001). 
Regarding to this mechanism study, the selective IP3R blocker, 2-aminoethoxydiphenyl 
borate (2-APB) is commonly used.  
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1.5.2(b)(ii) Ryanodine receptor (RyRs) 
This receptor is less likely distributed in vascular, however, it plays minor role in 
controlling the intracellular release of Ca
2+
 ions into the cytosol by using calcium-
induced calcium release (CICR). The increasing Ca
2+
 ions concentration in cytosol will 
trigger the RyRs to release more Ca
2+
 ions from the SR store which subsequently causes 
a transient Ca
2+
 spark, which is important for muscle contraction.  
1.5.2(b)(iii) Store-operated Ca
2+
 channel (SOCC) 
The primary function of SOCC is to refill Ca
2+
 ions, and it is known as capacitative-
dependent calcium entry channel whereby its activation across the plasma membrane 
will occur with the depletion of the Ca
2+
 stores (Feletou and Vanhoutte, 2005, 
McFadzean and Gibson, 2002). The sacro/endoplasmic reticulum Ca
2+
-ATPase (SERCA) 
is the only specialized pumps used to transport the Ca
2+
 ions from the extracellular into 
the SR store to re-accumulate the calcium concentration back to the range between 0.5-1 
mM. In the SR store, the Ca
2+
 ions will bind to calsequestrin with the purpose of 
decreasing the free mobile Ca
2+
 ions in the SR, hence more calcium can be stored 
(Chemaly et al., 2013, Swietach et al., 2008, Wood, 2016). The selective SOCC blocker, 
gandolinium (Gd 
3+
) is usually accompanied with the use of the selective blocker of 






Figure 1.1: Overall signaling mechanism pathways that happen in vascular 





In summary, there are plenty of signaling mechanism pathways mediating vascular 
tone regulation as shown in Figure 1.1. However, in the signaling mechanism studies of 
vasodilatory effect of drugs, there are a few major vasodilation-predominated signaling 
pathways that need to be studied and investigated such as NO, PGI2, sGC, cGMP, 
muscarinic receptors, β2-adrenergic receptors, Kca, Kv, Kir, KATP, VOCC, and IP3R. 
According to the literature, all these pathways were frequently studied in the in vitro 
antihypertensive pharmacological research related to vasculature (Loh et al., 2016, 
Rameshrad et al., 2016). All these signaling mechanism studies have been included in 
this thesis as well.  
1.6 Problem Statements 
Despite there are varieties of synthetic antihypertensive drugs available in the current 
market, there are often many scientific reports on their relatively low efficacies in term 
of monotherapy as well as undesired chronic adverse effects (Düsing, 2010). According 
to the trend of antihypertensive drugs evolution, the classes of antihypertensive drugs 
used clinically often changes from year-to-year with the purpose of achieving the 
targeted blood pressure range. For instance, the development of antihypertensive drugs 
have evolved in such an order: Rauwolfia alkaloid, reserpine, thiazides, β-blockers, 
calcium-channel blockers (CCBs), α-blockers, angiotensin-converting-enzyme inhibitor 
(ACEI), angiotension II-receptor blockers (ARBs), and direct renin inhibitor (DRI) 
Aliskiren. However, according to the Clinical Practice Guidelines in Management of 
Hypertension (4
th
edition) in Malaysia, the favored choice of first line monotherapy has 
included only five classes from the aforementioned including ACEI, ARBs, CCB, 
diuretic-thiazide, and β-blockers, and report stated that only 35% of the patients’ blood 
pressure was successfully controlled by treatment (MOH, 2013). Therefore, combination 
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therapy is often preferred and was claimed to be more effective in achieving the target 
blood pressure. At the same time, approximately 60% of the hypertensive patients in 
Europe countries require ≥2 antihypertensive agents to reach the desired blood pressure 
(MOH, 2013). Because of this, the US, European Society of Hypertension (ESH) and 
European Society of Cardiology (ESC) guidelines have provided a few options for two 
drugs combinations such as the combination of diuretic with either CCBs or 
ACEI/ARBs, while only a single remedy for three drugs combination such as 
ACEI/ARBs with CCBs plus a diuretic (Düsing, 2010). Thus, the discovery of new 
antihypertensive drugs is still a hot topic in the field of pharmaceutical research.  
From the perspective of traditional Chinese medicine (TCM), it employs a 
syndromatic treatment system which treats diseases based on its syndromes. Based on 
the principles of TCM, hypertension is a multi-syndromic disease that is caused by 
phlegm fluid retention, fire, and deficiencies syndromes.  The first syndrome is fire 
syndrome that could further categorized into four types such as liver fire, heart fire, 
stomach fire or intestine fire. The second syndrome is the phlegm-fluid retention 
syndrome. The third syndrome is deficiency syndrome that normally happens in the 
spleen or the kidney (Qian et al., 2003, Wang and Xiong, 2013). Since ancient times, 
TCM herbs have been shown to be capable of providing extraordinary therapeutic effect 
in the treatment of hypertension based on their holistic benefits along with insignificant 
arise of safety concern. Moreover, the combination of TCM herbs could possibly 
enhance the therapeutic effect of the main herb in eliciting its vasodilatory effect. These 
phenomena could be attributed to the variety of vasoactive components present in the 
combined TCM herbs, which could tackle hypertension through multiple signaling 
mechanism pathways simultaneously.  
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In this study, five TCM herbs that are frequently used as clinical prescriptions to 
counteract different syndromes caused by the hypertension which includes Gastrodia 
elata, Uncaria rhynchophylla, Pueraria thomsonii, Panax notoginseng, and Alisma 
orientale were selected for antihypertensive drugs research by using orthogonal 
stimulus-response compatibility group studies with L25 (5
5
) formulation. The high 
performance thin layer chromatography (HPTLC) and Fourier transform infrared (FTIR) 
spectroscopy identification methods were used to authenticate the fingerprints of the five 
herbs by comparison to their respective marker compounds before the experiments 
started. The vasodilatory effects of formulated combined herbs were determined by 
using in vitro aortic rings assay, followed by oral administration to the spontaneous 
hypertensive rats (SHRs) for 28 days consecutively in different dosages along with 
toxicology study. The formulated combined herbs was expected to exert strongest 
vasodilatory effects using holistic mechanism of actions compared to single herbal 
extract, as well as to exhibit a strong antihypertensive effects in in vivo whilst without 
causing adverse effect in animal models.  
1.7 Objectives 
The main objectives of present study were 
a) To investigate the vasodilatory effects of the most potent extracts from G. elata, 
U. rhynchophylla, P. thomsonii, P. notoginseng, and A. orientale using in vitro 
aortic rings assay. 
b) To determine the optimum ratio of combining five most potent solvent extracts 
from five TCM herbs by using L25 (5
5
) formulation orthogonal stimulus-response 
compatibility group studies (named as F1). 
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c) To determine the most suitable solvent to extract U. rhynchophylla, P. thomsonii, 
P. notoginseng, and A. orientale that prepared in optimized ratio (F1) to exert the 
highest vasodilatory effect using in vitro aortic rings assay. 
d) To study the mechanism of action of vasodilatory effects for the ratio optimized 
combination of five TCM herbs (F1-2) using in vitro aortic rings assay, and 
partial characterization on its vasoactive components using tri-step Fourier 
transform infrared spectroscopy and high performance thin layer 
chromatography. 
e) To determine the antihypertensive and toxicity effects of F1-2 via in vivo study 



















HERBAL AUTHENTICATION USING HIGH PERFORMANCE THIN LAYER 




As aforementioned, the five TCM herbs which include G.elata, U. rhynchophylla, P. 
thomsonii, P. notoginseng, and A. orientale were selected for this antihypertensive drug 
research based on their own capability to cure the specific syndromes caused by the 
hypertension. Before the experiment carried put, the authenticity of the five purchased 
raw herbs was assured macroscopically upon purchasing from the local medical hall by 
the TCM’s expert, Dr. Yam Mun Fei. After that, the fingerprints of five herbs were 
identified by using high performance thin layer chromatography (HPTLC) and tri-step 
Fourier transform infrared (tri-step FTIR) spectroscopy methods. 
2.1.1 High-performance thin layer chromatography (HPTLC) 
Basically, all herbs may contain highly complex mixtures of compounds that cover a 
wide range of substance classes and they are used to exhibit natural variability. 
Therefore, the choice of selecting an appropriate analytical method is crucial in order to 
achieve highly reliable and reproducible results, both in qualitative and quantitative 
manners. HPTLC fingerprint is one of the ideal analytical methods that can be used to 
identify the complex herbal entities (Sai Saraswathi et al., 2017). Fundamentally, 
HPTLC is the improved form of TLC, by using the same principles, the mobile phase 
promotes the separation of compound mixtures by differential migration according to 
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their polarity across the stationary phase, subsequently the TLC plate will be examined 
under UV light with different wavelength and the distances travelled by the separated 
substances will be calculated as retention factor (Rf). However, HPTLC provides extra 
credits by providing enormous flexibility in the selection of the parameters for different 
analysis, enhanced resolution, automation steps, and highly accurate quantitative 
measurements. HPTLC is known as a powerful and rapid analytical tool due to its high 
flexibility, precision, and accuracy (Maldini et al., 2016). The automation steps of the 
HPTLC has tremendously enhanced the reproducibility of the quantitative results, and 
thus it was proposed to be included in various pharmacopeia (Gîtin et al., 2014, John et 
al., 2015, Motisariya et al., 2013, Pikul et al., 2013). In this section, the HPTLC 
fingerprints of each raw herb were compared to the fingerprints of their standard herbs 
that were purchased from National Institutes for Food and Drug Control, China, as well 
as compared with their marker compounds that were purchased from Chengdu Biopurify 
Phytochemicals Ltd, Sichuan, China in order to prove the authenticity of the raw herbs.  
2.1.2 Tri-step Fourier transform infrared spectroscopy (tri-step FTIR) 
The principles applied in tri-step FTIR is same with FTIR whereby it measures the 
infrared radiation absorbed or emitted by the substances which normally appears in mid-
IR (5000-400 cm
-1
) or near-IR region (10000-4000 cm
-1
), and rarely in far-IR region 
(200 cm
-1
), and the resulting absorption peak appeared in the spectrum corresponds to 
the bonds present in the molecules of the substances. Tri-step FTIR consists of three 
types of identifications methods such as conventional FTIR (1D-IR), second-derivative 
IR (SD-IR), and 2D-correlation IR (2D-IR) spectroscopy. Tri-step FTIR is easy and 
rapid, and is used to provide highly reproducible fingerprint results which make it the 
golden identification method in determining the authenticity of TCM materials. The 
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main advantage of tri-step FTIR is that the sample does not need to undergo any 
destructive chemical or physical perturbation processes such as fractionation which 
could cause the original samples to behave differently, and therefore the most complete 
and true information among the relationship between different chemical compounds in 
each herb can be obtained (Sun et al., 2011).  
During the spectra interpretation, some of the characteristic peaks would be too 
small due to the low concentration of a particular chemical constituent within the sample, 
or had been unintentionally masked by bigger peaks, thus those peaks were invisible for 
interpreting in the 1D-IR spectra. Therefore, the SD-IR spectroscopy with its higher 
resolution can be used to solve this problem by emphasizing the hidden peaks in the SD-
IR spectra (Sun et al., 2003). Moreover, the 2D-IR spectroscopy is the next step to 
compensate the drawbacks of other analytical systems by exposing the samples to 
external perturbation, and therefore altering the intra- and intermolecular relationship of 
the chemical constituents within the samples. Subsequently, the relationship between 
functional groups could be analyzed from the dynamic spectra obtained (Li et al., 2014, 
Li et al., 2015). In this section, the 1D-IR spectra of raw herbs were compared to the 
standard herbs that were purchased from National Institutes for Food and Drug Control, 
China to prove their authenticity. 
2.2 Methodology 
2.2.1 Herbs and chemicals 
The G. elata, U. rhynchophylla, P. thomsonii, P. notoginseng, and A. orientale raw 
herbs were purchased from the local medical hall and macroscopically authenticated by 
the expert of TCM, Dr. Yam Mun Fei. The G. elata, U. rhynchophylla, P.lobata, P. 
notoginseng, and A. orientale standard herbs were purchased from National Institute for 
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Food and Drug Control (Beijing, China). The marker compounds such as gastrodin, 
rhynchophylline, isorhynchophylline, puerarin, ginsenoside Rb1, ginsenoside Rg1, and 
alisol B acetate were purchased from Chengdu Biopurify Phytochemicals Ltd (Sichuan, 
China). HPTLC 60G F254 plate and potassium bromide (KBr) were bought from Merck 
(Germany). Chloroform, ethyl acetate, formic acid, petroleum ether, and ethanol were 
purchased from QReC (New Zealand). Methanol was purchased from J. T. Baker (USA).  
2.2.2 High performance thin layer chromatography 
All samples were freshly prepared on the day of analysis. G. elata, U. rhynchophylla, 
P. thomsonii, P. notoginseng, and A. orientale raw and standard herbs were prepared in 
concentration of 100 mg/ml by dissolving in methanol separately. The marker 
compounds preparations for each herb were described at 2.2.2(a)-(e). After that, all the 
samples were centrifuged at 3500 rpm for 15 min at room temperature, and the 
supernatant was transferred into vials prior to analysis. These experiments were carried 
out by using the HPTLC developed by CAMAG which is equipped with the automatic 
developing chamber (ADC 2), automatic TLC sampler 4 (ATS 4), TLC visualizer, and 
TLC scanner 4. All data were interpreted by using VisionCATs software version 
2.2.16187.4 (CAMAG, Muttenz, Switzerland). 
2 µl of each sample were applied as 8 mm width bands with 11.4 mm distance 
between bands on 20 X 10 cm HPTLC plate. The bands were applied at 8 mm distance 
from the bottom edge, and 20 mm distance from left edge. Methanol was used to rinse 
the spotting needle for three cycles when different samples were applied. The samples 
spotted TLC plate was transferred to ADC 2 which is equipped with a 20 X 10 cm twin-
through chamber containing 25 ml of mobile phase for saturation, and another 10 ml for 
development. Before the mobile phase developments, the chamber was saturated for 10 
